ClearPoint Neuro (CLPT) Net Margin (2011 - 2026)

ClearPoint Neuro has disclosed Net Margin across 15 years of filings, most recently posting 78.76% for Q1 2026.

• Net Margin for Q1 2026 came in at 78.76%, down 774.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 71.57% (down 706.0% YoY), and the FY2025 annual result was 69.08%, down 883.0% from the prior year.
• Net Margin came in at 78.76% for Q1 2026 at ClearPoint Neuro, down from 74.79% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 54.27% in Q1 2024 to a low of 119.85% in Q2 2023.
• The 5-year median for Net Margin is 73.75% (2022), against an average of 76.24%.
• Across the five-year window, Net Margin tumbled 3725 bps in 2023 and soared 6375 bps in 2024, its largest moves.
• ClearPoint Neuro's Net Margin stood at 86.37% in 2022, then gained by 20 bps to 69.1% in 2023, then slipped by 0 bps to 69.31% in 2024, then slipped by 8 bps to 74.79% in 2025, then fell by 5 bps to 78.76% in 2026.
• The last three Net Margin figures came in at 78.76% (Q1 2026), 74.79% (Q4 2025), and 66.48% (Q3 2025), per Business Quant data.